Molecular Tumor Board: 77 year-old female with a history of ER+/PR+/HER2- right breast cancer and new lung mass with EGFR exon 19 deletion and ALK fusion

Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

BURLINGTON, N.C. , Sept. 14, 2023 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City , expected to conclude by approximately 4:00 p.m. ET .

Jennifer Ennis, MD

Dr. Ennis provides clinical direction and oversight for Labcorp's portfolio of customer-facing technology solutions and leads a team of clinicians in creating content for the portfolio.

Megan Hartranft, PharmD, BCOP

Dr. Megan Hartranft is a Clinical Lead with the Clinical and Digital Solutions team, advising on precision oncology products.

65th ASH Annual Meeting and Exposition

San Diego, CA  

Association of Molecular Pathology (AMP) 2023 Annual Meeting & Expo

Salt Lake City, UT

ACCC 40th National Oncology Conference

T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy